Published in Magn Reson Imaging on January 01, 1986
What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc (2015) 1.19
Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Metabolite 1H relaxation in normal and hyponatremic brain. Magn Reson Med (1996) 0.77
Longitudinal relaxographic imaging of white matter hyperintensities in the elderly. Fluids Barriers CNS (2014) 0.77
Imaging signatures of meningioma and low-grade glioma: a diffusion tensor, magnetization transfer and quantitative longitudinal relaxation time MRI study. Magn Reson Imaging (2015) 0.76
Magnetic resonance T2-relaxometry and 2D L-correlated spectroscopy in patients with minimal hepatic encephalopathy. J Magn Reson Imaging (2009) 0.75
Characterization of brain tumours with spin-spin relaxation: pilot case study reveals unique T 2 distribution profiles of glioblastoma, oligodendroglioma and meningioma. J Neurol (2017) 0.75
MRI assessment of experimental gliomas using 17.6 T. Neuroradiology (2013) 0.75
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Structure and function of a new STAT-induced STAT inhibitor. Nature (1997) 6.02
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol (1999) 5.65
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem (2001) 4.51
Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet (1997) 4.19
IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol (2000) 3.08
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75
Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc Natl Acad Sci U S A (1989) 2.72
T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J Immunol (1981) 2.46
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood (2000) 2.31
The inhomogeneous structure of water at ambient conditions. Proc Natl Acad Sci U S A (2009) 2.31
Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol (1982) 2.26
Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum (1998) 2.01
Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells. J Immunol (1985) 1.92
Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc Natl Acad Sci U S A (1998) 1.90
A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet (1999) 1.87
Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol (1988) 1.85
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest (2000) 1.85
Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery (1992) 1.84
Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet (1989) 1.79
Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma. Cancer (2000) 1.73
B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med (1983) 1.73
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol (2000) 1.72
Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res (2001) 1.70
cDNA cloning of a calcineurin B homolog in Saccharomyces cerevisiae. Biochem Biophys Res Commun (1991) 1.68
A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto) Ann Neurol (2000) 1.65
Effects of low oxygen on the release of dopamine from the rabbit carotid body in vitro. J Physiol (1982) 1.64
Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging (1996) 1.59
B cell growth and differentiation factors and mechanism of B cell activation. Immunol Rev (1984) 1.57
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum (1999) 1.57
Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells. J Immunol (1983) 1.57
Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis (2000) 1.56
An assessment of local curability of endoscopic surgery in early gastric cancer without satisfaction of current therapeutic indications. Endoscopy (1998) 1.53
Isolation and characterization of SSE1 and SSE2, new members of the yeast HSP70 multigene family. Gene (1993) 1.52
A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Neurology (1999) 1.52
Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther (1992) 1.51
Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res (2001) 1.50
Syringomyelia extending to the basal ganglia. Case report. J Neurosurg (1989) 1.48
Neuroendoscopic approach to tectal tumors: a consecutive series. J Neurosurg (1999) 1.48
In vitro antibody formation by human tonsil lymphocytes. J Immunol (1974) 1.47
Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology (1994) 1.46
Investigation of morphological change of lateral and midline fluid percussion injury in rats, using magnetic resonance imaging. Neurosurgery (1997) 1.45
Further studies on sperm-immobilizing antibody found in sera of unexplained cases of sterility in women. Am J Obstet Gynecol (1972) 1.45
Intracranial vascular stenosis and occlusion: diagnostic accuracy of three-dimensional, Fourier transform, time-of-flight MR angiography. Radiology (1994) 1.44
Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem (2000) 1.42
Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. Blood (1994) 1.42
[A case of traumatic aneurysm of the brachiocephalic artery]. Jpn J Thorac Cardiovasc Surg (1998) 1.41
Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology (1994) 1.40
Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Eur J Endocrinol (1996) 1.40
Accuracy of radiographic assessment for the diagnosis of invasion depth in small invasive colorectal cancer. Br J Radiol (2003) 1.39
[The clinical features of patients with probable dementia with Lewy bodies--report of 4 cases]. Rinsho Shinkeigaku (1999) 1.39
Chronological observation on the energy metabolism of skin flaps by 31P-MRS: a novel approach to evaluate the state of a flap. Plast Reconstr Surg (1993) 1.39
Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol (2001) 1.37
Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res (2004) 1.31
Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats. Neuroscience (1997) 1.30
Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I. Proc Natl Acad Sci U S A (2004) 1.30
T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects. Diabetologia (2003) 1.30
Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer Res (1994) 1.30
Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes (1998) 1.29
Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan. Transfusion (1997) 1.29
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet (2001) 1.26
Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol (1989) 1.26
Calpains play a role in insulin secretion and action. Diabetes (2001) 1.25
Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation (1995) 1.25
Chromosome of the enterohemorrhagic Escherichia coli O157:H7; comparative analysis with K-12 MG1655 revealed the acquisition of a large amount of foreign DNAs. DNA Res (1999) 1.24
Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy (2007) 1.24
Construction and evaluation of cDNA libraries for large-scale expressed sequence tag sequencing in wheat (Triticum aestivum L.). Genetics (2004) 1.23
Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT). Am Heart J (1999) 1.22
Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol (1994) 1.22
Intrathoracic multicentric Castleman disease: CT findings in 12 patients. Radiology (1998) 1.22
Growth and electric current loops in plants. Biophys Chem (1989) 1.20
Postnatal development of a brain-specific subspecies of protein kinase C in rat. J Neurosci (1988) 1.19
The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest (2001) 1.18
Immunocytochemical localization of protein kinase C subspecies in the rat spinal cord: light and electron microscopic study. J Comp Neurol (1990) 1.17
Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol (2003) 1.17
Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol (2000) 1.17
Congenital nodular multiple glomangioma: a case report. J Clin Pathol (2005) 1.14
Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer (2010) 1.14
Asplenia and polysplenia syndrome. Acta Pathol Jpn (1982) 1.14
[Interdural dermoid cyst of the cavernous sinus presenting with oculomotor palsy: case report]. No Shinkei Geka (1997) 1.14
Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol (2001) 1.13
Distinct cellular expression of calcineurin A alpha and A beta in rat brain. J Neurochem (1992) 1.12
Application of pulsed-gradient 31P NMR on frog muscle to measure the diffusion rates of phosphorus compounds in cells. Biophys J (1982) 1.12
Neuronal and glial localization of two GABA transporters (GAT1 and GAT3) in the rat cerebellum. Brain Res Mol Brain Res (1996) 1.11
Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci (1993) 1.11
Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood (1995) 1.11
Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation. Br J Pharmacol (1999) 1.10
Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br J Pharmacol (2000) 1.10
Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J Immunol (1984) 1.10
gamma-Aminobutyric acid in peripheral tissues. Life Sci (1985) 1.10
In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. Br J Pharmacol (2001) 1.09
Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. Oncogene (1991) 1.08
Relation of growth process to spatial patterns of electric potential and enzyme activity in bean roots. Biophys Chem (1987) 1.08
Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer (2010) 1.08
Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes (1997) 1.08
Distribution of protein kinase C-like immunoreactive neurons in rat brain. J Neurosci (1988) 1.07